Article info
Case report
Switching of monoclonal antibodies against calcitonin gene-related peptide in chronic migraine in clinical practice: a case series
- Correspondence to Dr María Del Pilar Briceño-Casado, Pharmacy, Hospital General Nuestra Señora del Prado, 45600 Talavera de la Reina, Castilla-La Mancha, Spain; pilarbricenocasado{at}gmail.com
Citation
Switching of monoclonal antibodies against calcitonin gene-related peptide in chronic migraine in clinical practice: a case series
Publication history
- Received July 3, 2021
- Accepted August 31, 2021
- First published September 14, 2021.
Online issue publication
June 22, 2023
Article Versions
- Previous version (14 September 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists 2023. No commercial re-use. See rights and permissions. Published by BMJ.